Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Alterity Therapeutics Receives FDA End-of-Phase 2 Meeting Minutes Confirming Registrational Pathway for ATH434 in Multiple System Atrophy
-
Gilat Receives $11 Million in U.S. Department of War Orders, Reinforcing Role in Mission-Critical Defense Connectivity
-
Stallion Uranium Defines Priority Target Areas from VTEM Survey on Stone Island Target, Moonlite Project
-
Vema Hydrogen and SAF+ International Group Partner to Produce Synthetic Sustainable Aviation Fuel for Canada’s Aviation Industry
-
WRAP Launches WrapShield: An Autonomous Defense & Public Safety Platform, Beginning with Advanced Thermal Polarimetric Sensing for Counter-UAS and Expanding Across AI-Enabled Security Responses
-
Dundee Corporation Announces the Start of Exploration at Westhaven’s Spences Bridge Gold Belt Properties, Southern British Columbia
-
Alfred University and Classiq Launch Quantum Computing Initiative
-
U.S. FDA Grants Priority Review to Agios’ sNDA for Mitapivat in Sickle Cell Disease
-
Kymera Therapeutics Appoints Elizabeth Laws, Ph.D., as Senior Vice President, Global Program Team Leader for KT-621, First-in-Class, Oral STAT6 Degrader
-
Westhaven Announces the Start of Exploration at the Spences Bridge Gold Belt Properties, Southern British Columbia
-
Aclarion Announces Texas Spine Care Center as New CLARITY Site
-
Fredonia Provides El Dorado Monserrat Project and Corporate Update
-
Miata Makes Significant New Discovery at Puma with 17.19 m at 3.14 g/t Au, and 21.64 m at 1.70 g/t Au
-
Aben Gold Provides Update on 2026 Drill Program at the Justin Gold-Tungsten Project
-
Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism
-
MariMed’s Nature’s Heritage Launches “The Nose Knows” Immersive, Science-Backed Consumer Education Campaign
-
Tvardi Therapeutics’ TTI-109 Phase 1 Study Confirms Prodrug Design, Improved Tolerability and Pharmacodynamic Evidence of STAT3 Target Engagement
-
American Lithium Highlights Renewed Momentum for Peru’s Mining Sector Following Keiko Fujimori’s Presidential Election Victory
-
VR completes 2,900 ft hole and polyphase vein intersection at its New Boston Moly-Tungsten-Copper-Silver Porphyry Project in Nevada; core scanning and continuous geochemistry are underway
-
Plug Wins 50MW Electrolyzer Order as Orica's Hunter Valley Hub Becomes the Largest Australian Renewable Hydrogen Project to Reach FID
-
Kailera Therapeutics Announces Positive Topline Data from Two Hengrui Pharma Phase 3 Clinical Trials of Oral Small Molecule GLP-1 Receptor Agonist HRS-7535/KAI-7535
-
OKYO Pharma to Participate in a Fireside Chat at Piper Sandler 2026 Virtual Ophthalmology Symposium
-
Crypto News Today: Pepeto Staking Pays 169% APY While Solana Price Targets $600
-
Troilus Drills 164 m Grading 0.95 g/t AuEq While Testing Unsampled Historic Drillhole Intervals in the Z87 Reserve Pit
-
WRAP Launches WrapShield: An Autonomous Defense & Public Safety Platform, Beginning with Advanced Thermal Polarimetric Sensing for Counter-UAS and Expanding Across AI-Enabled Security Responses
-
Annovis Reaches Full Enrollment in Pivotal Phase 3 Trial of Buntanetap for Early Alzheimer’s Disease
-
Aeluma CEO to Chair Optica Advanced Photonics Congress Industry Program on AI and Quantum
-
Axsome Therapeutics Initiates FOCUS-2 Phase 3 Trial of Solriamfetol in Children with Attention Deficit Hyperactivity Disorder (ADHD)
-
Plug Wins 50MW Electrolyzer Order as Orica's Hunter Valley Hub Becomes the Largest Australian Renewable Hydrogen Project to Reach FID
-
Healthcare Realty Trust Announces Second Quarter Earnings Release Date and Conference Call
-
onsemi Advances Fab Right Strategy with Agreements to Divest Two Manufacturing Facilities
-
ImageneBio Appoints Matt Robbins as General Counsel
-
Nuvini Retires R$61 Million Debenture Facility in Full
-
Aqua Metals Advances Headwaters ARC, Planned Midwest Battery Recycling and Critical Minerals Recovery Campus
-
Avalo Therapeutics to Participate in the Leerink Partners Therapeutics Forum
-
Solera Foundation’s WIND Movement Marks One Year of Global Impact, Spotlighting Darla Booher’s Leadership at NIADA Anniversary Celebration in Denver
-
Endogenex Announces Full Enrollment of the ReCET Clinical Study
-
Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism
-
AS Pro Kapital Grupp announces the extension of the maturity date of unsecured bonds
-
AC Immune to Showcase Neurodegenerative Disease Pipeline with Three Presentations at AAIC® 2026
-
HMNC Brain Health Announces Publication of Ketabon (KET01) Clinical Trial Results in JAMA Network Open
-
Teva to Advance Its Anti-IL-15 Antibody, Designed for Quarterly Dosing, Into Phase 2b Development in Vitiligo, Following Encouraging Phase 1b Results
-
Payfuture Launches Local Payments Integration for Merchants on Shopify in India
-
Fury Commences 2026 Drilling Program at Committee Bay in Nunavut
-
Toobit Brings Back $150K Copy Trading Challenge this July
-
YieldMax® ETFs Announces Weekly Distributions for Group 1 ETFs
-
YieldMax® ETFs Announces Distributions on BIGY, RNTY and SOXY
-
Liquidity Services Announces Third Quarter Fiscal Year 2026 Earnings Conference Call
-
Orezone Provides 2026 Guidance for Casa Berardi
-
FTAI Aviation and AEI Announce Strategic Collaboration to Meet Growing Demand for Boeing 737-800 Freighters
